bumetanide has been researched along with Adenoma Sebaceum in 1 studies
Adenoma Sebaceum: Facial ANGIOFIBROMA in tuberous sclerosis
| Excerpt | Relevance | Reference |
|---|---|---|
| "Bumetanide treatment is a potential treatment to alleviate the behavioral burden and quality of life associated with TSC." | 6.94 | Effects of bumetanide on neurodevelopmental impairments in patients with tuberous sclerosis complex: an open-label pilot study. ( Bruining, H; Jansen, FE; Oranje, B; Scheepers, FE; Sprengers, JJ; van Andel, DM, 2020) |
| "Bumetanide treatment is a potential treatment to alleviate the behavioral burden and quality of life associated with TSC." | 2.94 | Effects of bumetanide on neurodevelopmental impairments in patients with tuberous sclerosis complex: an open-label pilot study. ( Bruining, H; Jansen, FE; Oranje, B; Scheepers, FE; Sprengers, JJ; van Andel, DM, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| van Andel, DM | 1 |
| Sprengers, JJ | 1 |
| Oranje, B | 1 |
| Scheepers, FE | 1 |
| Jansen, FE | 1 |
| Bruining, H | 1 |
1 trial available for bumetanide and Adenoma Sebaceum
| Article | Year |
|---|---|
Effects of bumetanide on neurodevelopmental impairments in patients with tuberous sclerosis complex: an open-label pilot study.
Topics: Adolescent; Autism Spectrum Disorder; Bumetanide; Child; Disease Susceptibility; Duration of Therapy | 2020 |